Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
Klinički Bolnički Centar Zagreb
60 participants
Jun 1, 2026
INTERVENTIONAL
Conditions
Summary
Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.
Eligibility
Inclusion Criteria2
- Eligibility Criteria:
- \. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting
Exclusion Criteria5
- Left ventricular ejection fraction <30%
- Associated cardiac procedures
- Off-pump coronary artery bypass grafting
- Contraindications for MRI
- Inability to provide consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
CABG patients receiving Del Nido cardioplegia as the myocardial protection strategy
Patients will receive Blood Cardioplegia Solution for myocardial protection
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07637266